Haemodialysis and Peritoneal Dialysis Market by Type (Haemodialysis and Peritoneal Dialysis), Dialysis Site (Hospitals, Clinics & Dialysis Centers, and Home Dialysis), Modality (Conventional and Daily), and Product (Devices and Consumables) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
The haemodialysis and peritoneal dialysis market is projected to reach USD 76.9 billion in 2021, at a CAGR of 7.4% during the forecast period.
Dialysis is a technique used to remove waste products such as urea and creatinine from blood, which occurs from inappropriate functioning of kidneys and is usually required for people suffering from chronic renal failure. This procedure is performed for treating kidney disorders and is classified into 2 types: haemodialysis and peritoneal dialysis. In haemodialysis, blood is pumped out of blood vessels and is purified with the help of dialyzer and then returned back to the body through vascular access. In peritoneal dialysis, the principle of the procedure remains same, however the inner lining of stomach called peritoneum is used as a filter to purify blood.
Increasing number of ESRD patients, growing prevalence of diabetes & hypertension, shortage of organ donors and risks associated with transplants, technological advancements, and initiatives by leading players to introduce advanced products & services in the market are some of the factors that have supported long-term expansion for Haemodialysis and Peritoneal Dialysis Market.
North America dominates the haemodialysis and peritoneal dialysis market. Europe is gaining traction with the large dialysis patient base in the region.
Insights are provided for each region and major countries within the regions
Report Feature |
Descriptions |
---|---|
Market Revenue In 2021 |
USD 76.9 billion |
Growth Rate |
CAGR of 7.4% during the forecasting period, 2021-2028 |
Historical Data |
2018-2019 |
Forecast Years |
2021-2028 |
Base Year |
2020 |
Units Considered |
Revenue in USD billion and CAGR from 2021 to 2028 |
Report Segmentation |
type, product, modality type, dialysis site and region. |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
Asahi Kasei Medical Co., Ltd. (Subsidiary of Asahi Kasei Corporation), B. Braun Melsungen AG, Medtronic Plc, WEGO Healthcare (Shenzhen) Co., Ltd., Baxter International, Inc., Kawasumi Laboratories, Incorporation, Toray Industries, Inc., Nipro Corporation, Quanta Dialysis Technologies Limited, Becton, Dickinson and Company, Dialife SA, and Fresenius Medical Care AG & Co. KGaA. |
Available Customization |
In addition to the market data for Hemodialysis and Peritoneal Dialysis Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |
Haemodialysis and Peritoneal Dialysis Market is segmented into type, product, modality type, dialysis site and region.